No Picture
News

ImmixBio Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

LOS ANGELES: LOS ANGELES, July 23, 2021 /PRNewswire/ — Immix Biopharma, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to … […]

No Picture
News

ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim

LOS ANGELES: LOS ANGELES, July 23, 2021 /PRNewswire/ — ImaginAb Inc, a market leading global biotechnology company, focused on developing next generation immuno oncology imaging agents and therapeutic radiopharmaceuticals (RPT), today announced the si… […]